Is the failing heart energy starved? On using chemical energy to support cardiac function.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation Research

• Publication date

  2004-07-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.RES.0000137170.41939.D9PMID 15271865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Energetics: From Emax to Pressure-Volume Area

  2013cited by this paper
• Metabolic Generation and Utilization of Phosphate Bond Energy

  2006cited by this paper
• Energy metabolism in heart failure

  2004cited by this paper
• Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

  2004cited by this paper
• What Mechanisms Underlie Diastolic Dysfunction in Heart Failure?

  2004cited by this paper
• From energy store to energy flux: a study in creatine kinase deficient fast skeletal muscle

  2003cited by this paper
• Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells*

  2003cited by this paper
• Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart

  2003cited by this paper
• Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells.

  2003cited by this paper
• Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.

  2003cited by this paper
• Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles

  2003cited by this paper
• Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.

  2003cited by this paper
• Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

  2003cited by this paper
• Is depressed myocyte contractility centrally involved in heart failure?

  2003cited by this paper
• Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy.

  2003cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure

  2002cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-alpha in Pacing-Induced Heart Failure

  2002cited by this paper
• Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice

  2002cited by this paper
• An increase in the myocardial PCr/ATP ratio in GLUT4 null mice

  2002cited by this paper
• ATP and the Heart

  2002cited by this paper
• Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.

  2002cited by this paper
• AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation

  2002cited by this paper
• Metabolic myopathy in heart failure.

  2002cited by this paper
• Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth

  2002cited by this paper
• Myocardial creatine kinase expression after left ventricular assist device support.

  2002cited by this paper
• Energy Metabolism in the Hypertrophied Heart

  2002cited by this paper
• Genetic causes of inherited cardiac hypertrophy: Robert L. Frye Lecture.

  2002cited by this paper
• ATP and the Heart: An Overview

  2002cited by this paper
• Ways to Measure and Calculate Tissue Concentrations of ATP, ADP, AMP, Pi, and PCr and to Calculate ΔG ∼ATP

  2002cited by this paper
• Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.

  2002cited by this paper
• Energetic Crosstalk Between Organelles: Architectural Integration of Energy Production and Utilization

  2001cited by this paper
• Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy

  2001cited by this paper
• Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis.

  2001cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Chronic Phosphocreatine Depletion by the Creatine Analogue &bgr;-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction

  2001cited by this paper
• Metabolic Gene Expression in Fetal and Failing Human Heart

  2001cited by this paper
• THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE

  2000cited by this paper
• Metabolism--the lost child of cardiology.

  2000cited by this paper
• Kinetic, Thermodynamic, and Developmental Consequences of Deleting Creatine Kinase Isoenzymes from the Heart

  2000cited by this paper
• Preservation of glucose metabolism in hypertrophic GLUT4-null hearts.

  2000cited by this paper
• Distinct Roles for Recombinant Cytosolic 5′-Nucleotidase-I and -II in AMP and IMP Catabolism in COS-7 and H9c2 Rat Myoblast Cell Lines*

  2000cited by this paper
• Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy.

  2000cited by this paper
• Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement

  2000cited by this paper
• Myocardial oxygenation during high work states in hearts with postinfarction remodeling.

  1999cited by this paper
• Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine.

  1999cited by this paper
• Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy.

  1999cited by this paper
• Regulation of myocardial blood flow by oxygen consumption is maintained in the failing heart during exercise.

  1999cited by this paper
• The Molecular Energetics of the Failing Heart from Animal Models—Large Animal Models

  1999cited by this paper
• Subcellular creatine kinase alterations. Implications in heart failure.

  1999cited by this paper
• Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.

  1999cited by this paper
• The Molecular Energetics of the Failing Heart from Animal Models―Small Animal Models

  1999cited by this paper
• Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

  1999cited by this paper
• Melanoma vaccines: Prim and proper presentation

  1998cited by this paper
• Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial.

  1998cited by this paper
• Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology

  1998cited by this paper
• Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.

  1998cited by this paper
• Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

  1998cited by this paper
• Human myocardial ATP content and in vivo contractile function

  1998cited by this paper
• Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow.

  1998cited by this paper
• 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.

  1998cited by this paper
• Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

  1998cited by this paper
• Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow.

  1998cited by this paper
• Is the failing heart energy depleted?

  1998cited by this paper
• A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.

  1998cited by this paper
• The AMP-activated protein kinase--fuel gauge of the mammalian cell?

  1997cited by this paper
• Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart.

  1997cited by this paper
• Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts.

  1997cited by this paper
• Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Energetic basis for reduced contractile reserve in isolated rat hearts.

  1996cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• A Mouse Model of Familial Hypertrophic Cardiomyopathy

  1996cited by this paper
• Creatine kinase system in failing and nonfailing human myocardium.

  1996cited by this paper
• Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters.

  1996cited by this paper
• Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance.

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study.

  1995cited by this paper
• Glycogen Turnover in the Isolated Working Rat Heart (*)

  1995cited by this paper
• Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance.

  1995cited by this paper
• Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure.

  1995cited by this paper
• Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts.

  1995cited by this paper
• Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5'-nucleotidase.

  1994cited by this paper
• Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.

  1994cited by this paper
• Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.

  1994cited by this paper
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  1993cited by this paper
• Is cardiac failure a consequence of decreased energy reserve

  1993cited by this paper
• Cardiac metabolism in patients with dilated and hypertrophic cardio‐myopathy: Assessment with proton‐decoupled P‐31 MR spectroscopy

  1992cited by this paper
• High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.

  1992cited by this paper
• The american heritage dictionary of the english language

  1992cited by this paper
• Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding.

  1991cited by this paper
• Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

  1991cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

  1991cited by this paper
• Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy.

  1990cited by this paper
• Is the failing heart energy-starved?

  1990cited by this paper
• Ventricular energetics.

  1990cited by this paper
• Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.

  1990cited by this paper
• Regulation of oxidative phosphorylation in the mammalian cell.

  1990cited by this paper
• Relation between work and phosphate metabolite in the in vivo paced mammalian heart.

  1986cited by this paper

• Calcium ions as catalysts: Quantum chemical and experimental study of creatine cyclization to creatinine.

  2026cites this paper
• α1A-Adrenergic Receptor as a Target for Neurocognition: Cautionary Tale from Nicergoline and Quinazoline Non-Selective Blockers

  2025cites this paper
• The regulatory role of exercise in heart failure and myocardial energy metabolism: A review

  2025cites this paper
• Cardiomyopathy in a c.1528G>C Hadha mouse is associated with cardiac tissue lipotoxicity and altered cardiolipin species

  2025cites this paper
• The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

  2025cites this paper
• The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome.

  2025cites this paper
• Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery

  2025cites this paper
• ATP directly modulates thick filament structure and function in porcine myocardium

  2025cites this paper
• Efficacy and safety of creatine phosphate sodium in the treatment of viral myocarditis: A systematic review and meta-analysis

  2025cites this paper
• PERM1 Gene Delivery via AAV Prevents Heart Failure in a Mouse Model of Pressure Overload

  2025cites this paper
• Analysis and validation of characteristic genes in RNA sequencing datasets from heart failure patients based on multiple algorithms

  2025cites this paper
• Cyclophilin B deficiency enhances myocardial energy synthesis and protects against heart failure in preclinical models

  2025cites this paper
• ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine

  2025cites this paper
• Le découplage mécano-énergétique dans l’insuffisance cardiaque : de la physiopathologie aux nouvelles perspectives thérapeutiques

  2025cites this paper
• Life-long creatine deficiency leads to augmented sarcoplasmic reticulum calcium release but not heart failure.

  2025cites this paper
• CD36 knockdown attenuates pressure overload-induced cardiac injury by preventing lipotoxicity and improving myocardial energy metabolism

  2025cites this paper
• Acute Inhalation Exposure to Ultrafine Carbon Black Alters Mitochondrial Substrate Utilization in the Heart.

  2025cites this paper
• Mitochondrial function: A new direction for the targeted treatment of cardiovascular diseases with Chinese herbal medicine

  2025cites this paper
• Association of plasma metabolites and cardiac mitochondrial function with heart failure progression

  2025cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity.

  2024cites this paper
• Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect

  2024cites this paper
• Cardiomyocyte-specific deletion of GCN5L1 reduces lysine acetylation and attenuates diastolic dysfunction in aged mice by improving cardiac fatty acid oxidation.

  2024cites this paper
• A novel kinetic model to demonstrate the independent effects of ATP and ADP/Pi concentrations on sarcomere function

  2024cites this paper
• Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic Cardiomyopathy.

  2024cites this paper
• Mitochondrial calcium regulation of cardiac metabolism in health and disease.

  2024cites this paper
• Cadmium contributes to cardiac metabolic disruption by activating endothelial HIF1A-GLUT1 axis.

  2024cites this paper
• Advances in understanding and managing pediatric heart failure and transplant

  2024cites this paper
• Blunted Cardiac Mitophagy in Response to Metabolic Stress Contributes to HFpEF

  2024cites this paper
• The multifaceted role of mitochondria in cardiac function: insights and approaches

  2024cites this paper
• Maintaining energy provision in the heart: the creatine kinase system in ischaemia–reperfusion injury and chronic heart failure

  2024cites this paper
• TIGAR Deficiency Blunts Angiotensin-II-Induced Cardiac Hypertrophy in Mice

  2024cites this paper
• Human cardiac metabolism.

  2024cites this paper
• Compartmentalization in cardiomyocytes modulates creatine kinase and adenylate kinase activities

  2024cites this paper
• Pharmacological Interventions to Mitigate Immunodeficiency in Children with Congenital Heart Defects: A Review Article

  2024cites this paper
• Reactive oxygen species generation by reverse electron transfer at mitochondrial complex I under simulated early reperfusion conditions

  2024cites this paper
• Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• A self-reinforcing cycle hypothesis in heart failure pathogenesis

  2024influential citation
• Cardiac phenotype in adolescents and young adults with long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiency.

  2024cites this paper
• Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance

  2023cites this paper
• Asiatic acid protects against pressure overload-induced heart failure in mice by inhibiting mitochondria-dependent apoptosis.

  2023cites this paper
• Phosphorus Magnetic Resonance Spectroscopy (31P MRS) and Cardiovascular Disease: The Importance of Energy

  2023cites this paper
• Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy

  2023cites this paper
• Toxic effects of four emerging pollutants on cardiac performance and associated physiological parameters of the thick-shell mussel (Mytilus coruscus).

  2023cites this paper
• Functional Impact of Alternative Metabolic Substrates in Failing Human Cardiomyocytes

  2023cites this paper
• Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria

  2023cites this paper
• Striated preferentially expressed gene deficiency leads to mitochondrial dysfunction in developing cardiomyocytes

  2023cites this paper
• Individually tailored spatial–spectral pulsed CEST MRI for ratiometric mapping of myocardial energetic species at 3T

  2023cites this paper
• Targeting Mitochondrial Metabolism to Save the Failing Heart

  2023cites this paper
• The Lure of Cardiac Metabolism in the Diagnosis, Prevention, and Treatment of Heart Failure.

  2023cites this paper
• PGRMC1 Ablation Protects from Energy-Starved Heart Failure by Promoting Fatty Acid/Pyruvate Oxidation

  2023cites this paper
• Myocardial Metabolism in Heart Failure

  2023cites this paper
• α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease

  2023cites this paper
• Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19

  2023cites this paper
• Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

  2023cites this paper
• Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial

  2023cites this paper
• Reactive Oxygen Species Generation by Reverse Electron Transfer at Mitochondrial Complex I Under Simulated Early Reperfusion Conditions

  2023cites this paper
• Creatine phosphate improves myocardial function and myocardial enzyme profile in children with myocarditis

  2023cites this paper
• Developing a Machine Learning Algorithm for Improved Management of Congestive Heart Failure Patients in the Emergency Department

  2023cites this paper
• Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced myocardial energetic e�ciency

  2022cites this paper
• Modulation of Mitochondrial Bioenergetics by Polydopamine Nanoparticles in Human iPSC-Derived Cardiomyocytes.

  2022cites this paper
• CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases.

  2022cites this paper
• Ketones: the double-edged sword of SGLT2 inhibitors?

  2022cites this paper
• TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure

  2022cites this paper
• Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure.

  2022cites this paper
• Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy

  2022cites this paper
• Deciphering metabolic remodeling of the failing hearts

  2022cites this paper
• Disruption of mitochondria–sarcoplasmic reticulum microdomain connectomics contributes to sinus node dysfunction in heart failure

  2022cites this paper
• Human induced pluripotent stem cells for studying mitochondrial diseases in the heart

  2022cites this paper
• Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics

  2022cites this paper
• Evidence of altered fatty acid metabolism in dogs with naturally occurring valvular heart disease and congestive heart failure

  2022cites this paper
• Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

  2022cites this paper
• Pivotal role of vitamin D in mitochondrial health, cardiac function, and human reproduction

  2022cites this paper
• Ketogenic Diet and Cardiac Substrate Metabolism

  2022cites this paper
• Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure

  2022cites this paper
• Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

  2022cites this paper
• Mitochondrial ATP Synthase Tetramer Disassembly following Blood-Based or del Nido Cardioplegia during Neonatal Cardiac Surgery.

  2022cites this paper
• Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction.

  2022cites this paper
• Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure

  2022cites this paper
• SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

  2022cites this paper
• Heart Failure and Drug Therapies: A Metabolic Review

  2022cites this paper
• Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure

  2022cites this paper
• Targeting mitochondrial dysfunction with elamipretide

  2022cites this paper
• Remodeling of Cardiac Metabolism in Heart Failure with Preserved Ejection Fraction

  2022cites this paper
• Corticosteroid Receptors in Cardiac Health and Disease.

  2022cites this paper
• Insights Into the Metabolic Aspects of Aortic Stenosis With the Use of Magnetic Resonance Imaging

  2022cites this paper
• BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism

  2022cites this paper
• Traditional Chinese medicine enhances myocardial metabolism during heart failure.

  2021cites this paper
• Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

  2021cites this paper
• FAK regulates cardiomyocyte mitochondrial fission and function through Drp1

  2021cites this paper
• Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review

  2021cites this paper
• Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics

  2021cites this paper
• CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production

  2021cites this paper
• Creatine deficiency and heart failure

  2021cites this paper
• CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases

  2021cites this paper
• PCr/ATP ratios and mitochondrial function in the heart. A comparative study in humans

  2021cites this paper
• Long-Chain Acyl-Carnitines Interfere with Mitochondrial ATP Production Leading to Cardiac Dysfunction in Zebrafish

  2021cites this paper
• Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

  2021cites this paper
• Oral pre-treatment with thiocyanate (SCN−) protects against myocardial ischaemia–reperfusion injury in rats

  2021cites this paper
• Intravenous ferric carboxymaltose does not provide benefits in reperfused acute myocardial infarction in the rat with normal iron status.

  2021cites this paper